1486-69-7

Usage

Uses

Used in Pharmaceutical Industry:
3-O-Methylquercetin tetraacetate is used as a therapeutic agent for the treatment of various diseases, such as cancer, diabetes, and neurodegenerative diseases, due to its potential antioxidant and anti-inflammatory properties.
Used in Cancer Treatment:
3-O-Methylquercetin tetraacetate is used as an anticancer agent, as it has shown potential in inhibiting the growth and progression of cancer cells. Its chemical structure with four acetyl groups may enhance its stability and bioavailability, making it a promising candidate for further research and potential therapeutic applications in cancer treatment.
Used in Diabetes Management:
3-O-Methylquercetin tetraacetate is used as a potential treatment for diabetes, as it has been studied for its potential to improve insulin sensitivity and glucose metabolism, which can help in managing blood sugar levels.
Used in Neurodegenerative Disease Treatment:
3-O-Methylquercetin tetraacetate is used as a potential therapeutic agent for neurodegenerative diseases, as it has shown potential in protecting neurons and reducing inflammation, which can help in slowing down the progression of these diseases.

Upstream product

• 854693-27-9 3,4-bis-benzoyloxy-benzoic acid-anhydride 
• 69789-10-2 3,4-bis(benzoyloxy)benzoic acid 
• 69789-11-3 3,4-Dibenzoyloxybenzoylchlorid 
• 99-50-3 3,4-Dihydroxybenzoic acid 
• 55317-02-7 2-methoxy-1-(2,4,6-trihydroxyphenyl)ethanone 
• 1486-70-0 2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-methoxy-chromen-4-on 
• 108-24-7 acetic anhydride 

Relevant academic research and scientific papers

Phenylbenzopyrones structure-activity studies identify betuletol derivatives as potential antitumoral agents

We have analyzed the cytotoxicity of 22 compounds with a phenylbenzo-γ-pirone core structure, most of them obtained from natural sources, in five human tumor cell lines (HL-60, A431, SK-OV-3, HeLa and HOS). Betuletol 3-methyl ether and its diacetate were